Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Empowerment, not just education, may boost breast cancer screening in latinas

NCT ID NCT05841355

Prevention Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Aug 21, 2026 · Updated 3 times

Summary

This trial tests whether empowerment sessions can increase the number of Latina women who follow breast cancer screening guidelines. About 600 women who are overdue for a mammogram will be randomly assigned to either education sessions or empowerment sessions. Researchers will compare how many women in each group get their first and repeat mammograms on schedule.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Empowerment sessions and education sessions
What this could lead to
If it works, this could point toward a scalable way to increase breast cancer screening among Latina women who are overdue for mammograms.
What could go wrong
This is a behavioral intervention trial, so results may vary by community and setting. The benefit depends on whether empowerment sessions truly motivate long-term screening adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 74 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Aim 1 Inclusion Criteria: * female biological sex * identification as Latinas * non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis) * no previous history of health volunteerism * not a network member enrolled in Aim 2. Exclusion Criteria \* Not meeting at least one of the aforementioned Aim 1 inclusion criteria. Aim 2. Inclusion Criteria: * female biological sex * eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history) * referral from Aim 1 participants * no previous history of health volunteerism * no participation in the RCT (not an Aim 1 participant, no Session #3 attendance). Exclusion Criteria: * Not meeting at least one of the aforementioned Aim 1 inclusion criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer screening

Contacts and locations

Locations

  • Mile Square Health Center

    Chicago, Illinois, 60612, United States

  • University of Illinois Health

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.